Cancer research challenges in Ukraine | Cromos Pharma
Cancer research challenges in Ukraine In this article featured in Nature Journal, Vlad Bogin, MD, FACP, CEO of Cromos Pharma, offers insights into the prevailing challenges of conducting cancer research in Ukraine.
Empowering Patient Recruitment with Cromos Pharma: The Invaluable Role of Explainer Videos
Empowering Patient Recruitment with Cromos Pharma: The Invaluable Role of Explainer Videos In today’s fast-moving world, visual information holds a unique power to simplify complex ideas and connect deeply. This becomes especially important when communicating with patients who need to navigate the intricate world of clinical trials. Each trial comes with its own complexities, and we need a way to present them in an easily understandable manner.
Hemochromatosis screening and awareness month | Clinical Trials
Hemochromatosis Screening And Awareness Month Hemochromatosis: the Silent Iron Overload Disorder Hemochromatosis, a hereditary disorder characterized by excessive iron absorption and accumulation in the body, often goes undiagnosed or misdiagnosed due to its subtle symptoms. By understanding hemochromatosis, individuals can recognize the warning signs and seek appropriate medical attention, potentially preventing serious complications associated with iron overload. Screening for Hemochromatosis:

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM